2 recruiting, 1 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 2, Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow Central Venous Catheters: new trials by email Literature Review of Central Venous Catheters trials Research Report on Central Venous Catheters
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers Best Practice, Biospecimen Collection, Central Venous Cannula Insertion - Metastatic Bladder Urothelial Carcinoma, Metastatic Renal Pelvis and Ureter Urothelial Carcinoma | Phase 2 | Recruiting | Mayo Clinic | 70 | 2025-08-01 | 2026-05-08 |
| Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia Ascorbic Acid, Carboplatin, Cisplatin - Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Phase 2 | Recruiting | Mayo Clinic | 80 | 2018-03-23 | 2026-09-28 |
| Use of PiCCO System in Critically Ill Patients With Septic Shock and Acute Respiratory Distress Syndrome PiCCO monitoring (PULSION), central venous catheter - Septic Shock, Acute Respiratory Distress Syndrome | Phase 1 / Phase 2 | Completed | Jinhua Central Hospital | 350 | 2012-01-01 | 2015-05-04 |
Hodgkin Disease (1) · Leukemia, Myelomonocytic, Chronic (1) · Lymphoma (1) · Lymphoma, Large B-Cell, Diffuse (1) · Respiratory Distress Syndrome (1) · Shock, Septic (1) · Ureteral Neoplasms (1) · Urinary Bladder Neoplasms (1)
Mayo Clinic (2) · Jinhua Central Hospital (1)
United States (2) · China (1)
Jacob J. Orme, MD, PhD (1) · Thomas E Witzig, M.D. (1) · Zhongheng Zhang, MD (1)
P50CA097274 (1)